Last Updated: September 24, 2026

KYXATA Drug Patent Profile

Name: KYXATA Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Kyxata, and when can generic versions of Kyxata launch?

Kyxata is a drug marketed by Avyxa Holdings and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in KYXATA is carboplatin. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the carboplatin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Kyxata

A generic version of KYXATA was approved as carboplatin by HOSPIRA on October 14^th, 2004.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for KYXATA?
What are the global sales for KYXATA?
What is Average Wholesale Price for KYXATA?

Summary for KYXATA

US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
What excipients (inactive ingredients) are in KYXATA?	KYXATA excipients list
DailyMed Link:	KYXATA at DailyMed

Drug patent expirations by year for KYXATA

Pharmacology for KYXATA

Drug Class	Platinum-based Drug

US Patents and Regulatory Information for KYXATA

KYXATA is protected by one US patents.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avyxa Holdings	KYXATA	carboplatin	SOLUTION;INTRAVENOUS	219921-001	Aug 8, 2025		DISCN	Yes	No	12,427,104	⤷ Start Trial	Y			⤷ Start Trial
Avyxa Holdings	KYXATA	carboplatin	SOLUTION;INTRAVENOUS	219921-002	Aug 8, 2025		RX	Yes	Yes	12,427,104	⤷ Start Trial	Y			⤷ Start Trial
Avyxa Holdings	KYXATA	carboplatin	SOLUTION;INTRAVENOUS	219921-003	Aug 8, 2025		RX	Yes	Yes	12,427,104	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for KYXATA

Kyxata cost?
Kyxata price?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.